動態

• 

  Mary Grace N. Tamio   shared news

  在 May 26 2024 at 08:30 PM 已編輯 public

  SLC7A5 correlated with malignancies and immunotherapy response in bladder cancer
  
  #immunotherapy #bladdercancer #journals #articles
  
  More info | ⬇️

  

  SLC7A5 correlated with malignancies and immunotherapy response in bladder cancer

  Metabolic reprogramming contributes to bladder cancer development. This study aimed to understand the role of SLC7A5 in bl...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 07 2024 at 09:13 PM 已編輯 public

  Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
  
  #breastcancer #tumor #immunotherapy #drugresistance #journals #articles
  
  More info | ⬇️

  

  Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer

  Breast cancer, the most frequent female malignancy, is often curable when detected at an early stage. The treatment of met...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 31 2024 at 08:43 PM 已編輯 public

  Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment
  
  #immunotherapy #cancer #ovariancancer #journals #articles
  
  More info | ⬇️

  

  Unlocking the ‘ova’-coming power: immunotherapy’s role in shaping the future of ovarian cancer treatment

  Ovarian cancer is a prominent cancer worldwide with a relatively low survival rate for women diagnosed. Many individuals a...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 January 11 2024 at 10:23 PM 已編輯 public

  Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy
  
  #ovariancancer #immunotherapy #journals #articles
  
  More info | ⬇️

  

  Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy

  medRxiv - The Preprint Server for Health Sciences
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 July 21 2023 at 09:22 PM 已編輯 public

  PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma
  
  #immunotherapy #hepatocellularcarcinoma #journals #articles
  
  More info |⬇️

  

  PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma

  PTEN often mutates in tumors, and its manipulation is suggested to be used in the development of preclinical tools in canc...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享